Efficacy of adjuvant chemotherapy stratified by age and the 21-gene recurrence score in estrogen receptor-positive breast cancer

BACKGROUND: The 21-gene recurrence score (RS) can predict chemotherapy benefit in estrogen receptor-positive, human epidermal growth factor receptor-2-negative (ER+/HER2-) early breast cancer patients. Age would influence the interaction between RS and chemotherapy effect. The current study aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Jing, Lin, Caijin, Huang, Jiahui, Hong, Jin, Gao, Weiqi, Zhu, Siji, Lin, Lin, Chen, Xiaosong, Huang, Ou, He, Jianrong, Zhu, Li, Chen, Weiguo, Li, Yafen, Wu, Jiayi, Shen, Kunwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8207606/
https://www.ncbi.nlm.nih.gov/pubmed/34130640
http://dx.doi.org/10.1186/s12885-021-08461-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8207606/
https://www.ncbi.nlm.nih.gov/pubmed/34130640
http://dx.doi.org/10.1186/s12885-021-08461-9

Ejemplares similares